DEFA14A: USANA Health Sciences Seeks Shareholder Approval for 2025 Equity Incentive Plan, Announces Annual Meeting Details

USANA Health Sciences is soliciting proxies for its upcoming Annual Meeting of Shareholders, featuring proposals including the election of directors, approval of the 2025 Equity Incentive Plan, and ratification of KPMG as the independent auditor.

Summary

• USANA Health Sciences, Inc. is holding its Annual Meeting of Shareholders on May 19, 2025, via live webcast.
• Shareholders of record as of March 10, 2025, are eligible to vote on several proposals.
• The proposals include electing eight directors, approving the 2025 Equity Incentive Plan, ratifying the selection of KPMG LLP as the independent auditor for fiscal year 2025, and approving executive compensation on an advisory basis.
• The Board of Directors recommends voting 'FOR' all listed proposals.
• The 2025 Equity Incentive Plan aims to attract and retain employees, consultants, and directors by aligning their interests with those of shareholders.
• The plan authorizes the issuance of up to 2,500,000 shares of common stock, plus shares available from the 2015 plan.
• The company's fiscal year 2024 operating results reflected continued, cautious consumer sentiment across most of its markets, as net sales declined 7.2% and adjusted diluted earnings per share declined 21% compared to fiscal year 2023.
• The Compensation Committee approved the 2025 Executive Bonus Plan and designated constant currency net sales growth and adjusted operating profit as the performance objectives under the plan.
• The Compensation Committee approved a three percent (3%) base salary increase for each NEO for Fiscal Year 2025.

Sentiment

Score: 6

Explanation: The document is primarily informational, outlining meeting details and proposals. While there are positive aspects like the new equity plan and Hiya Health acquisition, the negative financial results temper the overall sentiment.

Positives

• The 2025 Equity Incentive Plan is designed to attract and retain qualified employees and directors.
• The plan aligns the interests of executives with those of shareholders through equity-based compensation.
• The company is committed to sound corporate governance practices, including independent directors and risk oversight.
• The company reorganized its sales, marketing, and communications departments into one commercial team to better position it to execute its customer growth strategy.
• The company completed its acquisition of Hiya Health Products, LLC, a fast growing, profitable, direct-to-consumer children's wellness brand.

Negatives

• Fiscal year 2024 operating results reflected continued, cautious consumer sentiment across most of its markets, as net sales declined 7.2% and adjusted diluted earnings per share declined 21% compared to fiscal year 2023.

Risks

• The company's future performance depends on its ability to attract and retain qualified personnel.
• The company faces risks related to regulatory compliance and potential litigation.
• The company's financial results are subject to market conditions and consumer sentiment.
• The company's future performance depends on its ability to generate long-term growth.

Future Outlook

The company believes that initiatives implemented in 2024 will lay the foundation for long-term growth.

Management Comments

• Kevin Guest, Executive Chairman of the Board, invites shareholders to participate in the Annual Meeting.
• The Board believes that the 2025 Plan is necessary to continue attracting and retaining well-qualified employees and directors.

Industry Context

The document references peer groups of publicly traded direct selling, nutritional, and personal product companies for benchmarking compensation and performance.

Comparison to Industry Standards

• The document compares USANA's executive compensation to a Compensation Peer Group of 15 publicly traded direct selling, nutritional or personal product companies.
• The Performance Peer Group consists of other publicly traded direct selling companies and is used to assess (i) our operating performance relative to the performance of these direct peer companies, and (ii) the appropriateness of our incentive plan payout relative to this peer group.
• The document utilizes the Performance Peer Group in the Pay vs. Performance Table contained in this Proxy Statement as required by Item 402(v) of Regulation S-K to assess total shareholder return relative to the peer group.

Related Party Transactions

• The Company was not a party to any related party transactions in 2024 that required disclosure.

Stakeholder Impact

• Shareholders are directly impacted by the proposals being voted on, including the election of directors and the approval of the equity incentive plan.
• Employees and executives are impacted by the equity incentive plan and executive compensation decisions.
• The company's performance impacts all stakeholders, including customers and suppliers.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Shareholders on May 19, 2025.
• The Compensation Committee will utilize the materials from CODA to render executive compensation decisions for Fiscal Year 2025.

Key Dates

Keywords

Equity Incentive Plan, Annual Meeting, Executive Compensation, Board of Directors, Shareholders, KPMG, Directors, USANA, Compensation